RE: Regional Nodal Irradiation After Breast-Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial

被引：2
|
作者：
Belkacemi, Yazid [1 ,2 ]
Kuten, Abraham [3 ,4 ]
机构：
[1] UPEC, Henri Mondor Univ Hosp, AP HP, Dept Radiat Oncol, Creteil, France
[2] UPEC, Henri Mondor Breast Canc Ctr, INSERM, U955,EQ 07, Creteil, France
[3] Technion Israel Inst Technol, Italian Hosp, Haifa, Israel
[4] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2018年 / 110卷 / 05期
关键词：
D O I：
10.1093/jnci/djx241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：539 / 540
页数：2
相关论文
共 50 条
  • [21] Factors Associated with Re-excision after Breast-Conserving Surgery for Early-Stage Breast Cancer
    Jung, Woohyun
    Kang, Eunyoung
    Kim, Sun Mi
    Kim, Dongwon
    Hwang, Yoonsun
    Sun, Young
    Yom, Cha Kyong
    Kim, Sung-Won
    JOURNAL OF BREAST CANCER, 2012, 15 (04) : 412 - 419
  • [22] Management of HER2-Positive Early Breast Cancer
    Steger, Guenther
    Lueftner, Diana
    Stoeger, Herbert
    Thurlimann, Beat
    Untch, Michael
    BREAST CARE, 2018, 13 (06) : 453 - 455
  • [23] Adjuvant Regional Irradiation after Breast-conserving Therapy for Early Stage Breast Cancer: a Survey of Canadian Radiation Oncologists
    Clavel, S.
    Roy, I.
    Carrier, J. -F.
    Rousseau, P.
    Fortin, M. -A.
    CLINICAL ONCOLOGY, 2010, 22 (01) : 39 - 45
  • [24] Cosmetic Results after adjuvant Irradiation in breast conserving Surgery for Breast cancer
    Sautter-Bihl, M. -L.
    Sedlmayer, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (04) : 425 - 427
  • [25] Radiation Therapy for Early-Stage Breast Cancer after Breast-Conserving Surgery
    Buchholz, Thomas A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (01): : 63 - 70
  • [26] Identification of biologically-driven HER2-positive breast cancer subgroups associated with prognosis after adjuvant trastuzumab in the ALTTO trial
    Rediti, M.
    Venet, D.
    Garcia, A. Joaquin
    Agbor-Tarh, D.
    Maetens, M.
    Vincent, D.
    Majjaj, S.
    El-Abed, S.
    Liu, M. C.
    Di Cosimo, S.
    Piccart, M.
    Pusztai, L.
    Loi, S.
    Salgado, R. F.
    Viale, G.
    Rothe, F.
    Sotiriou, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S602 - S603
  • [27] EFFECTIVENESS OF RADIOTHERAPY TECHNIQUES AFTER BREAST-CONSERVING SURGERY IN PATIENTS WITH EARLY BREAST CANCER
    Trofimova, O. P.
    Mikhina, Z. P.
    Ivanov, S. M.
    Gutnik, R. A.
    Yazhgunovich, I. P.
    Vekova, N. V.
    Timoshkina, E. V.
    Poddubskaya, E. V.
    Tkachev, S. I.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2014, 6 (02) : 45 - 49
  • [28] Regional recurrence in breast cancer patients with one to three positive axillary lymph nodes treated with breast-conserving surgery and whole breast irradiation
    Hirata, Kimiko
    Yoshimura, Michio
    Inoue, Minoru
    Yamauchi, Chikako
    Ogura, Masakazu
    Toi, Masakazu
    Suzuki, Eiji
    Takeuchi, Megumi
    Takada, Masahiro
    Hiraoka, Masahiro
    JOURNAL OF RADIATION RESEARCH, 2017, 58 (01) : 79 - 85
  • [29] The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO
    Di Cosimo, S.
    Campbell, C.
    Azim, H. A., Jr.
    Galli, G.
    Bregni, G.
    Curigliano, G.
    Criscitiello, C.
    Izquierdo, M.
    de la Pena, L.
    Fumagalli, D.
    Fein, L.
    Vinholes, J.
    Ng, W. M. J.
    Colleoni, M.
    Ferro, A.
    Naume, B. J.
    Patel, A.
    Huober, J.
    Piccart-Gebhart, M. J.
    Baselga, J.
    de Azambuja, E.
    EUROPEAN JOURNAL OF CANCER, 2018, 89 : 42 - 48
  • [30] Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients
    Johnson, Jeffrey E.
    Strassle, Paula D.
    de Oliveira, Guilherme C.
    Agala, Chris B.
    Spanheimer, Philip
    Gallagher, Kristalyn
    Ollila, David
    Muss, Hyman
    Downs-Canner, Stephanie
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (02) : 509 - 520
12345